Blood test shows high accuracy in detecting stage I non-small cell lung cancer

BACKGROUND: In a previous study (Goebel et. al, Cancer Genomics Proteomics 16:229-244, 2019), we identified 33 biomarkers for an early stage (I-II) Non-Small Cell Lung Cancer (NSCLC) test with 90% accuracy, 80.3% sensitivity, and 95.4% specificity. For the current study, we used a narrowed ensemble...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Cancer
Hoofdauteurs: Goebel, Cherylle, Louden, Christopher L., Mckenna, Robert, Onugha, Osita, Wachtel, Andrew, Long, Thomas
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2020
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7035746/
https://ncbi.nlm.nih.gov/pubmed/32085733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-6625-x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items